Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition

Journal of the American Society of Nephrology

Volumn 25, Issue 12, 2014, Pages 2752-2763

  Giani, Jorge F ^a   Janjulia, Tea ^a   Kamat, Nikhil ^b   Seth, Dale M ^c   Blackwell, Wendell Lamar B ^a   Shah, Kandarp H ^a   Shen, Xiao Z ^a   Fuchs, Sebastien ^d   Delpire, Eric ^e   Toblli, Jorge E ^f   Bernstein, Kenneth E ^a   McDonough, Alicia A ^b   Gonzalez Villalobos, Romer A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL ALEMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRORENIN; RENIN; SODIUM CHANNEL; SODIUM CHLORIDE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 2; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; SODIUM PROTON EXCHANGE PROTEIN 3; COTRANSPORTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SYNTHESIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MOUSE; MOUSE MODEL; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM RETENTION; SODIUM TRANSPORT; TREATMENT RESPONSE; URINE VOLUME; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CHEMISTRY; KIDNEY; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; GLOMERULAR FILTRATION RATE; HYPERTENSION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NATRIURESIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDYL-DIPEPTIDASE A; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RENIN; SYMPORTERS;

EID: 84923342170     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013091030     Document Type: Article

References (38)

1. Ng KK, Vane JR: Conversion of angiotensin I to angiotensin II. Nature 216: 762-766, 1967
2. Atlas SA: The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13[Suppl B]: 9-20, 2007
3. Alderman MH, Cohen HW, Sealey JE, Laragh JH: Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 17: 1-7, 2004
4. van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA: Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: Does it exist and does it affect the antihypertensive response? J Hypertens 10: 803-812, 1992
5. Nussberger J, Brunner DB, Waeber B, Brunner HR: Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans. J Hypertens Suppl 3: S269-S270, 1985
6. Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F, Corvol P: The angiotensin converting enzyme in the kidney. J Hypertens Suppl 7: S9-S13; discussion S14, 1989
7. Erdös EG, Skidgel RA: Structure and functions of human angiotensin I converting enzyme (kininase II). Biochem Soc Trans 13: 42-44, 1985
8. Gonzalez-Villalobos RA, Janjoulia T, Fletcher NK, Giani JF, Nguyen MT, Riquier-Brison AD, Seth DM, Fuchs S, Eladari D, Picard N, Bachmann S, Delpire E, Peti-Peterdi J, Navar LG, Bernstein KE, McDonough AA: The absence of intrarenal ACE protects against hypertension. J Clin Invest 123: 2011-2023, 2013
9. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA: Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011
10. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993
11. Johnson RA, Freeman RH: Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol 266: R1723-R1729, 1994
12. Graciano ML, Cavaglieri RC, Dellê H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL: Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004
13. Shen XZ, Li P, Weiss D, Fuchs S, Xiao HD, Adams JA, Williams IR, Capecchi MR, Taylor WR, Bernstein KE: Mice with enhanced macrophage angiotensin-converting enzyme are resistant tomelanoma. Am J Pathol 170: 2122-2134, 2007
14. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE: Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90: 87-92, 2002
15. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE: Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104: 839-844, 2001
16. Zhao D, Seth DM, Navar LG: Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension 54: 120-126, 2009
17. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990, 2006
18. Giani JF, Muñoz MC, Pons RA, Cao G, Toblli JE, Turyn D, Dominici FP: Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol 300: F272-F282, 2011
19. Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE: Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43: 854-859, 2004
20. Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG: Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 298: F150-F157, 2010
21. Schreiber A, Shulhevich Y, Geraci S, Hesser J, Stsepankou D, Neudecker S, Koenig S, Heinrich R, Hoecklin F, Pill J, Friedemann J, Schweda F, Gretz N, Schock-Kusch D: Transcutaneous measurement of renal function in conscious mice. Am J Physiol Renal Physiol 303: F783-F788, 2012
22. Navar LG, Satou R, Gonzalez-Villalobos RA: The increasing complexity of the intratubular Renin-Angiotensin system. J Am Soc Nephrol 23: 1130-1132, 2012
23. Ramkumar N, Ying J, Stuart D, Kohan DE: Overexpression of Renin in the collecting duct causes elevated blood pressure. Am J Hypertens 26: 965-972, 2013
24. Ying J, Stuart D, Hillas E, Gociman BR, Ramkumar N, Lalouel JM, Kohan DE: Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens 25: 684-689, 2012
25. Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, Hase N, Suzaki Y, Sigmund CD, Navar LG: Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol 293: F938-F945, 2007
26. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS: RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69: 1016-1023, 2006
27. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I: Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23: 1181-1189, 2012
28. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez-Iturbe B: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281: F38-F47, 2001
29. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science 252: 1813-1816, 1991
30. Mitchell KD, Navar LG: Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am J Physiol 255: F383-F390, 1988
31. Thorup C, Persson AE: Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol 267: F606-F611, 1994
32. Hashimoto S, Adams JW, Bernstein KE, Schnermann J: Micropuncture determination of nephron function in mice without tissue angiotensin-converting enzyme. Am J Physiol Renal Physiol 288: F445-F452, 2005
33. Baylis C: Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9, 2008
34. Singh P, Deng A, Weir MR, Blantz RC: The balance of angiotensin II and nitric oxide in kidney diseases. Curr Opin Nephrol Hypertens 17: 51-56, 2008
35. Mattson DL, Meister CJ: Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice. Am J Physiol Regul Integr Comp Physiol 289: R991-R997, 2005
36. Zou AP, Cowley AW Jr: Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension 29: 194-198, 1997
37. Cowley AW Jr, Ryan RP, Kurth T, Skelton MM, Schock-Kusch D, Gretz N: Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats. Hypertension 62: 85-90, 2013
38. Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, Katsurada A, Tran DV, Kobori H, Navar LG: Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295: F772-F779, 2008